Cargando…
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy
The prognostic significance of initial prostate-specific antigen (PSA) level for metastatic prostate cancer remains uncertain. We investigated the differences in prognosis and response to hormonal therapies of metastatic prostate cancer patients according to initial PSA levels. We analyzed 184 patie...
Autores principales: | Yamada, Yasutaka, Sakamoto, Shinichi, Amiya, Yoshiyasu, Sasaki, Makoto, Shima, Takayuki, Komiya, Akira, Suzuki, Noriyuki, Akakura, Koichiro, Ichikawa, Tomohiko, Nakatsu, Hiroomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116678/ https://www.ncbi.nlm.nih.gov/pubmed/29735818 http://dx.doi.org/10.4103/aja.aja_24_18 |
Ejemplares similares
-
Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis
por: Yamada, Yasutaka, et al.
Publicado: (2017) -
Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients
por: Kanesaka, Manato, et al.
Publicado: (2021) -
Outcomes of patients older than 75 years with non-metastatic prostate cancer
por: Amiya, Yoshiyasu, et al.
Publicado: (2017) -
Long-term outcomes of nonpalpable prostate cancer (T1c) patients treated with radical prostatectomy
por: Amiya, Yoshiyasu, et al.
Publicado: (2015) -
Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer
por: Sakamoto, Shinichi, et al.
Publicado: (2019)